Table 1.
Baseline patient characteristics of the study population
| Characteristic | Value |
|---|---|
| Sex, male | 62% |
| Age (years) | 62 (55–71) |
| Dialysis duration (years) | 10.2 (3.8–14.4) |
| Body mass index (kg/m2) | 21.2 (18.8–23.1) |
| Serum albumin (g/dL) | 3.7 (3.5–3.9) |
| Hemoglobin (g/dL) | 10.5 (9.8–11.2) |
| Intact parathyroid hormone (pg/mL) | 206 (124–320) |
| Calcium (mg/dL) | 9.5 (9.0–10.0) |
| Phosphate (mg/dL) | 5.4 (4.5–6.2) |
| Cause of end-stage renal disease | |
| Glomerulonephritis | 45% |
| Diabetic nephropathy | 25% |
| Comorbidities | |
| Cardiovascular disease | 61% |
| Malignancy | 5% |
| History of parathyroidectomy | 6% |
| Vitamin D receptor activators | |
| Intravenous | 53% |
| Oral | 30% |
| None | 17% |
| Phosphate binders | |
| Calcium-based | 40% |
| Non-calcium-based | 20% |
| Both | 26% |
| None | 14% |
| Cinacalcet | 20% |
Data are expressed as median (interquartile range) or proportion